Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02554045Phase 4Completed
Phase 4, randomised, open-label trial in erectile dysfunction (ED) and obesity comparing Tadalafil with Placebo (2 arms). Primary endpoints: Variation in lean mass at 8 weeks and Variation in fat mass at 8 weeks. Started Jan 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02554045.